Outsourcing, particularly to regions with lower production costs, has become a common practice among pharmaceutical companies. Countries like India and China have emerged as major players in the API manufacturing landscape, offering cost-effective solutions while maintaining compliance with international standards. However, this trend also raises concerns about the quality of APIs and supply chain vulnerabilities, highlighting the need for robust quality assurance mechanisms.
In addition to technical expertise and scalability, many pharmaceutical intermediates manufacturers are also adopting sustainable practices. With growing concerns about environmental impact and sustainability, these manufacturers are increasingly looking at green chemistry principles to minimize waste, reduce energy consumption, and utilize safer solvents. This shift not only benefits the environment but also enhances the manufacturer’s reputation and ensures compliance with emerging regulations focused on sustainable practices in the pharmaceutical sector.
PQQ, a redox cofactor that is naturally present in the body and found in foods like spinach, green peppers, and fermented soybeans, has emerged as a potent mitochondrial protectant. Preliminary studies suggest that PQQ may enhance mitochondrial biogenesis, the process by which new mitochondria are formed within cells. This could be particularly beneficial in situations where mitochondrial function is compromised, such as in aging or chronic disease.
mitochondrial basics with pqq